title: Absence of fragile X syndrome in Nova Scotia.
authors.forename: R G
authors.initials: RG
authors.lastname: Beresford
authors.forename: C
authors.initials: C
authors.lastname: Tatlidil
authors.forename: D C
authors.initials: DC
authors.lastname: Riddell
authors.forename: J P
authors.initials: JP
authors.lastname: Welch
authors.forename: M D
authors.initials: MD
authors.lastname: Ludman
authors.forename: P E
authors.initials: PE
authors.lastname: Neumann
authors.forename: W L
authors.initials: WL
authors.lastname: Greer
mesh_terms: D017954:Africa South of the Sahara / Q000453:epidemiology; D002681:China / Q000453:epidemiology; D005060:Europe / Q000453:epidemiology; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics; D006801:Humans; D008297:Male; D009419:Nerve Tissue Proteins / Q000235:genetics; D009674:Nova Scotia / Q000453:epidemiology; D015995:Prevalence; D016601:RNA-Binding Proteins; D014481:United States / Q000453:epidemiology
chemical_list: D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human